Newsfeeds - Spark Newswire

1 minute read

Pre-Market Outlook

Benzinga Pro’s Top 5 Stocks To Watch For Tuesday, Sept. 7, 2021: PLAY, SPOT, MTCH, BMRN, RNXT

Today, 1:57 PM

Today's 5 Stock Ideas: Dave & Buster's Entertainment (PLAY) - The company reports Q2 earnings Thursday, September 9th. Spotify (SPOT) - Share up ~5% premarket. Keybanc upgraded the stock

BMRN

2 minute read

FDA Slaps Clinical Hold on BioMarin’s Gene Therapy For Genetic Metabolism Disorder

By Vandana Singh

Today, 1:57 PM

â€‹â€‹â€‹â€‹â€‹â€‹BioMarin Pharmaceutical Inc (NASDAQ:BMRN) faces another setback in its gene therapy development program after the FDA placed the phenylketonuria (PKU)…

BMRN

1 minute read

Drug For Short-Limbed Dwarfism From Biomarin Wins European Approval

By Vandana Singh

Today, 1:57 PM

The European Commission (EC) has approved BioMarin Pharmaceutical Inc’s (NASDAQ:BMRN) Voxzogo (vosoritide) once-daily injection to treat achondroplasia. The approval covers children…

BMRN

4 minute read

FDA
News

European Commission Approves BioMarin’s VOXZOGO (vosoritide) For Treatment Of Children With Achondroplasia From Age 2 Until Growth Plates Close

By Benzinga Newsdesk

Today, 1:57 PM

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that the European Commission (EC) has granted marketing authorization for VOXZOGO® (vosoritide), a once daily injection to treat achondroplasia in children

BMRN

1 minute read

RBC Capital Maintains Sector Perform on Biomarin Pharmaceutical, Raises Price Target to $88

By Benzinga Newsdesk

Today, 1:57 PM

RBC Capital analyst Kennen MacKay maintains Biomarin Pharmaceutical (NASDAQ:BMRN) with a Sector Perform and raises the price target from $87 to $88.

BMRN

5 minute read

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer’s Conference, IPOs and More

By Shanthi Rexaline

Today, 1:57 PM

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start to the pharma reporting season.

ABBV

1 minute read

BioMarin Shares 5-Year Data From Open-Label Trial Of Hemophilia Gene Therapy

By Vandana Singh

Today, 1:57 PM

BioMarin Pharmaceutical Inc (NASDAQ: BMRN)

BMRN

4 minute read

Biomarin Pharmaceutical Announces Oral Presentation At International Society On Thrombosis And Haemostasis 2021 Virtual Congress

By Benzinga Newsdesk

Today, 1:57 PM

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today new data for valoctocogene roxaparvovec, an investigational gene therapy treatment for adults with severe hemophilia A, from its open-label Phase 1/2 study

BMRN

1 minute read

BioMarin Unveils News Data From Late-Stage Hemophilia A Gene Therapy Candidate

By Vandana Singh

Today, 1:57 PM

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) has announced new data from GENEr8-1 Phase 3 study for valoctocogene roxaparvovec, investigational gene therapy for severe…

BMRN

11 minute read

BioMarin Announces Oral Presentation Of 1-Year Results From Phase 3 Pivotal Trial With Valoctocogene Roxaparvovec Gene Therapy In Adults With Sever Hemophilia A At International Society On Thrombosis A nd Haemostasis 2021 Virtual Congress

By Benzinga Newsdesk

Today, 1:57 PM

BioMarin Announces Oral Presentation of Positive One-Year Results from Phase 3 Pivotal Trial with Valoctocogene Roxaparvovec Gene Therapy in Adults with Severe Hemophilia A at International Society on Thrombosis and

BMRN